#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15552	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2062	748.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	920	C	859	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3720	744.6	0	.	n	.	0	T695C	SNP	695	695	T	1132	1132	C	857	C,T	802,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3720	744.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1774	1774	A	938	A,G	871,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3720	744.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2408	2408	C	894	C,T	823,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3720	744.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2482	2482	A	868	A	818	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3720	744.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3034	3034	C	869	C	821	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1910	folP	855	855	100.0	folP.l15.c30.ctg.1	1668	114.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1023	1025	AGC	196;198;197	A;G;C	186;186;184	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4942	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3394	145.1	1	SNP	p	S91F	1	.	.	271	273	TTC	549	551	TTC	149;148;147	T;T;C	141;139;140	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4942	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3394	145.1	1	SNP	p	D95G	1	.	.	283	285	GGC	561	563	GGC	141;141;143	G;G,A;C,A,T	135;133,1;133,1,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4942	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3394	145.1	1	SNP	p	G95N	0	.	.	283	285	GGC	561	563	GGC	141;141;143	G;G,A;C,A,T	135;133,1;133,1,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1504	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1336	112.2	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	197;198;198	G;G;C	186;186;185	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	758	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1029	73.2	0	.	n	.	0	A197.	DEL	197	197	A	590	590	A	186	A	174	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5140	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	175.8	1	SNP	p	D86N	0	.	.	256	258	GAC	572	574	GAC	201;202;203	G;A;C	188;187;191	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5140	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	175.8	1	SNP	p	R87W	0	.	.	259	261	CGT	575	577	CGT	206;207;208	C;G;T	193;195;195	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5140	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	175.8	1	SNP	p	R87I	0	.	.	259	261	CGT	575	577	CGT	206;207;208	C;G;T	193;195;195	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5140	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	175.8	1	SNP	p	S87R	1	.	.	259	261	CGT	575	577	CGT	206;207;208	C;G;T	193;195;195	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5140	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	175.8	1	SNP	p	S88P	0	.	.	262	264	TCC	578	580	TCC	211;211;210	T;C;C	197;197;198	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4278	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2667	159.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1514	1516	GGC	226;225;224	G;G;C	203;202;203	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1284	1286	GCA	217;213;211	G;C;A	203;196;198	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1287	1289	ATC	211;212;214	A;T;C	199;196;198	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1299	1301	GTG	205;203;202	G;T;G	189;191;187	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1299	1301	GTG	205;203;202	G;T;G	189;191;187	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1803	1805	ACC	190;191;191	A;C;C	174;177;178	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1857	1859	GCG	181;179;178	G;C;G	160;147;150	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1857	1859	GCG	181;179;178	G;C;G	160;147;150	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1980	1982	GGC	135;135;137	G;G;C	127;127;129	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1989	1991	GGC	137;134;133	G;G;C	123;122;121	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3834	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2448	155.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2007	2009	CCG	116;115;112	C,CGG;C;G	82,1;83;80	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5626	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3131	179.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1688	1690	CCG	204;203;204	C,A;C;G	183,1;187;189	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2082	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1909	108.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	749	749	C	144	C	133	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	380	382	GAA	235;232;233	G;A;A	219;218;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	668	670	GAT	214;216;220	G;A;T	198;201;204	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	791	793	TCA	230;230;232	T;C;A	211;211;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	920	922	GTC	239;235;238	G;T;C	222;222;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	932	934	TCT	246;248;249	T;C;T	231;234;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	G255E	NONSYN	763	765	GGA	1031	1033	GAA	237;237;234	G;A,G;A	223;221,1;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	H294R	NONSYN	880	882	CAT	1148	1150	CGT	282;286;281	C;G;T	265;268;254	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1250	1252	GCA	242;243;244	G;C;A	229;229;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	1	SNP	p	G120K	1	.	.	358	360	AAG	626	628	AAG	218;216;215	A;A;G	207;206;204	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	1	SNP	p	A121D	1	.	.	361	363	GAC	629	631	GAC	215;213;210	G,T;A;C	201,1;200;200	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2874	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1657	171.3	1	SNP	p	D121N	0	.	.	361	363	GAC	629	631	GAC	215;213;210	G,T;A;C	201,1;200;200	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10726	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4912	217.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1210	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1005	119.0	1	SNP	p	V57M	1	.	.	169	171	ATG	516	518	ATG	244;244;239	A;T;G	226;226;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
